Short-Read Next-Generation DNA Sequencing System
ID: NIAID-SS-24-2225904Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/fca0c28dc55b4b3189c0e991c5f8db6a/view
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotations for a next-generation DNA sequencing system under Solicitation ID RFQ-NIAID-24-2225904. This procurement aims to enhance laboratory capabilities for rare variant discovery in viral research, requiring the system to demonstrate high accuracy (≥90%), compatibility with existing library formats, and the ability to detect low-frequency variants down to 0.001%. The selected vendor will be responsible for providing a system that meets specific technical specifications, along with training for researchers and a one-year warranty, with a prompt delivery expected within 90 days post-award to Bethesda, Maryland. Interested vendors should submit detailed quotes, including pricing and compliance documentation, to Matt Lear at matt.lear@nih.gov by the specified deadline.

    Point(s) of Contact
    Matt Lear
    (240) 669-5109
    matt.lear@nih.gov
    Files
    Title
    Posted
    RFQ_AMBIS 2225904 Amendment 1.pdf
    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotations for a next-generation DNA sequencing system under Solicitation ID RFQ-NIAID-24-2225904. This acquisition aims to enhance the capacity for rare variant discovery in viral research. The instrument is required to meet specific performance criteria, including high accuracy, compatibility with existing library formats, and the ability to detect low-frequency variants without unique molecular indices. The contract will be awarded based on technical specifications and pricing, following FAR guidelines for simplified acquisitions. Interested vendors must submit detailed quotes including pricing, shipping, and compliance documentation, highlighting their ability to meet technical requirements. A prompt delivery within 90 days post-award is sought, with a preferred delivery location in Bethesda, Maryland. This solicitation emphasizes the need for thorough compliance with government terms and technical standards to ensure a responsible selection process.
    RFQ_AMBIS 2225904 Final.pdf
    The National Institute of Allergy and Infectious Diseases (NIAID) has issued a Request for Quotation (RFQ-NIAID-24-2225904) for a next-generation DNA sequencing system to enhance its laboratory capabilities for rare variant discovery. The acquisition will be processed under Simplified Acquisition Procedures and is not set aside for small businesses. The required system must demonstrate high accuracy (≥90%), compatibility with existing library formats, and the ability to detect variants down to 0.001%. Specific physical dimensions for the sequencer and cluster generator are mandated, along with training for researchers and a one-year warranty. Vendors are invited to submit quotes that include pricing, shipping costs, country of origin, and evidence of manufacturer or authorized distributor status, as well as compliance with all technical specifications. The government will evaluate submissions based on technical compliance and price, and successful vendors must comply with electronic invoicing processes. This solicitation reflects the government's ongoing commitment to advancing scientific research capabilities while adhering to federal procurement regulations and standards.
    Sources Sought - Final.pdf
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), has issued a Sources Sought notice seeking information about a next-generation short-read DNA sequencing system. This initiative aims to procure a high-performance sequencer that enhances the research capacity of the Laboratory for Viral Diseases by facilitating rare variant discovery with improved sensitivity. Key requirements for the sequencing system include high accuracy, compatibility with existing library formats, the ability to detect low-frequency variants, and specific technical specifications for dimensions and software capabilities. Additionally, the procurement will cover instrument installation and training for researchers, as well as a warranty period. Interested vendors are invited to submit their capability statements and relevant information by August 20, 2024. This notice does not constitute a formal solicitation but aims to gather information from potential vendors to determine market availability and capabilities regarding this high-tech laboratory equipment. The anticipated award date for the project is September 27, 2024, signaling a commitment to advance research methodologies in virology through improved DNA sequencing technologies.
    Lifecycle
    Title
    Type
    Short-Read Next-Generation DNA Sequencing System
    Currently viewing
    Solicitation
    Short-Read Next-Generation DNA Sequencing System
    Sources Sought
    Similar Opportunities
    SOURCES SOUGHT: Long read sequencing services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide long read sequencing services as part of the Global Parkinson’s Genetics Program (GP2). The objective is to genotype over 150,000 individuals worldwide to enhance understanding of genetic risk factors associated with Parkinson’s Disease, requiring the contractor to perform long read sequencing on 500 human genomic DNA samples with a minimum coverage of 25X per sample, alongside ancillary services such as DNA fragmentation, library preparation, and bioinformatics support. Interested parties must submit their capability statements by November 15, 2024, at 9:00 AM Eastern Time, to Rashiid Cummins at rashiid.cummins@nih.gov, ensuring compliance with the specified guidelines and format.
    CYTEK AURORA 5 LASER WITH LOADER - UV/V/B/YG/R - PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a premium service agreement for a Cytek Aurora 5 laser with loader, which is essential for advanced laboratory applications. The procurement includes comprehensive maintenance services, such as preventive inspections, technical support, and on-site assistance, ensuring optimal functionality of the equipment throughout the contract period from December 1, 2024, to November 20, 2025. This acquisition is critical for supporting the NIH's research initiatives in allergy and infectious diseases, emphasizing the importance of reliable laboratory equipment and services. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 13, 2024, at 12:00 am EST, and can contact Maliaka Pinkney or Jesse D Weidow for further inquiries.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking sources for the procurement of Illumina Reagents and Consumables. This opportunity aims to identify potential suppliers capable of providing essential reagents and consumables used in genomic sequencing and related research applications. These products are critical for advancing biomedical research and supporting various health initiatives. Interested vendors should reach out to Ethan Mueller at ethan.mueller@nih.gov for further details regarding this sources sought notice.
    Qiagen LLC QIAsymphony DSP DNA Midi Kits, filter tips and supplies
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to issue a sole source firm fixed-price purchase order to Qiagen LLC for QIAsymphony DSP DNA Midi Kits, filter tips, and related supplies, essential for the Microbiology Service section of the Department of Laboratory Medicine. This procurement aims to acquire reagents and supplies necessary for the efficient extraction of nucleic acids from clinical samples, which is critical for timely detection of infectious agents and supporting ongoing clinical testing. The items will be utilized with existing QIAsymphony SP and QIAgility instruments, which are vital for the laboratory's operations and the development of novel tests. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 2:30 PM EST, as this is not a request for proposals.
    MAINTENANCE CONTRACT FOR THERMO ELECTRON CORP QEHF-LC EQUIPMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a maintenance contract for Thermo Electron Corp Q-EHF-LC equipment, crucial for the Laboratory of Immune System Biology's research efforts. The procurement involves maintenance services for a high-demand mass spectrometer and associated laboratory equipment, ensuring accurate data collection and system functionality. This maintenance is vital to prevent delays in critical research, as the equipment is used for analyzing irreplaceable samples. Interested vendors must contact Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov for further details, with the solicitation number RFQ-NIAID-25-2243700 issued under Simplified Acquisition Procedures.
    J--NextSeq2000 Maintenance Agreement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Child Health and Development (NICHD), intends to award a non-competitive contract to Illumina, Inc. for a maintenance agreement on the NextSeq2000 sequencing system. This agreement is crucial for ensuring the optimal performance of the sequencer, which is utilized for genetic analyses related to mental health conditions, particularly alcohol use disorder. The maintenance contract will cover preventative maintenance, emergency repairs, and necessary updates from December 24, 2024, to December 23, 2025, with Illumina being the sole provider capable of servicing this specialized equipment. Interested parties may submit their qualifications by November 25, 2024, and for further inquiries, they can contact Jacob M. Balenson at jacob.balenson@nih.gov or call 301-827-8302.
    Preventive Maintenance and Repair Services for a PacBio Sequel II next generation sequencer
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking qualified vendors to provide Preventive Maintenance and Repair Services for a PacBio Sequel II next generation sequencer, Serial Number: SQ64096, on behalf of the National Center for Toxicological Research (NCTR). The procurement includes a base year of service and three option years, with requirements for scheduled preventive maintenance visits, unlimited corrective maintenance, and technical support, all performed by OEM-certified engineers using OEM-certified parts. This equipment is crucial for the NCTR's research activities, and responses to this sources sought announcement must be submitted by November 8, 2024, to Warren Dutter at warren.dutter@fda.hhs.gov, with no contract awarded from this announcement.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    BIO-RAD LABORATORIES, INC. CSP, QX200 DIGITAL PCR W/ADG OS DIGITAL PCR SYSTEMS W/AUTO DG SERVICE CONTRACT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is planning to award a sole source fixed-price contract to Bio-Rad Laboratories, Inc. for a service contract related to two QX200 AutoDG ddPCR Systems. The contract will cover a twelve-month base year with four additional option years, focusing on essential maintenance and support services to ensure compliance with FDA regulations and optimal operational performance of the equipment. These systems are critical for assessing gene modification efficiency in cellular therapy products, which directly impacts treatment decisions and patient outcomes. Interested parties may express their interest and capabilities to Tasha Lowe at lowet2@mail.nih.gov by November 9, 2024, at 12 PM, as the government retains discretion over the procurement process.